Bariatric endoscopy with endoluminal therapies is a rapidly evolving field. Endoscopic Sleeve Gastroplasty (ESG) has gained significant momentum following the publication of Level 1 evidence from the MERIT trial, subsequent FDA approval, and the expanding role of revision procedures such as REVISE interventions, including Transoral Outlet Reduction (TORe) and sleeve gastrectomy revision. Despite these advances, there remains a critical need for structured, high-quality training to ensure safe adoption and optimal outcomes.

Register Now